NIH SBIR: Ability of Frio Oral Rinse to Lowe3r CV Risk - Clinical Part

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/139/30/14

Funding

  • Biomedical Development Corporation: $105,459.00